These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7820711)

  • 1. Prognostic value of the immediate response to surfactant.
    Kuint J; Reichman B; Neumann L; Shinwell ES
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant.
    Herting E; Speer CP; Harms K; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; McClure G; Reid M
    Biol Neonate; 1992; 61 Suppl 1():26-30. PubMed ID: 1391262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
    Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
    Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial.
    Bevilacqua G; Parmigiani S; Robertson B
    J Perinat Med; 1996; 24(6):609-20. PubMed ID: 9120744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants.
    Lang MJ; Hall RT; Reddy NS; Kurth CG; Merritt TA
    J Pediatr; 1990 Feb; 116(2):295-300. PubMed ID: 2405141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth.
    Walti H; Boulé M; Moriette G; Relier JP
    Biol Neonate; 1992; 61 Suppl 1():48-53. PubMed ID: 1391266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary effects after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Farstad T; Bratlid D
    Biol Neonate; 1995; 68(4):246-53. PubMed ID: 8580215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome].
    Herting E; Tubman R; Halliday HL; Harms K; Speer CP; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):721-7. PubMed ID: 8413348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome.
    Herting E; Möller O; Schiffmann JH; Robertson B
    Acta Paediatr; 2002; 91(11):1174-8. PubMed ID: 12463314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.